BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 23624693)

  • 1. Decreases in the numbers of peripheral blood regulatory T cells, and increases in the levels of memory and activated B cells, in patients with active eosinophilic granulomatosis and polyangiitis.
    Tsurikisawa N; Saito H; Oshikata C; Tsuburai T; Akiyama K
    J Clin Immunol; 2013 Jul; 33(5):965-76. PubMed ID: 23624693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An increase of CD83+ dendritic cells ex vivo correlates with increased regulatory T cells in patients with active eosinophilic granulomatosis and polyangiitis.
    Tsurikisawa N; Saito H; Oshikata C; Tsuburai T; Ishiyama M; Mitomi H; Akiyama K
    BMC Immunol; 2014 Aug; 15():32. PubMed ID: 25174446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innate immune response reflects disease activity in eosinophilic granulomatosis with polyangiitis.
    Tsurikisawa N; Oshikata C; Watanabe M; Tsuburai T; Kaneko T; Saito H
    Clin Exp Allergy; 2018 Oct; 48(10):1305-1316. PubMed ID: 29908086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose intravenous immunoglobulin treatment increases regulatory T cells in patients with eosinophilic granulomatosis with polyangiitis.
    Tsurikisawa N; Saito H; Oshikata C; Tsuburai T; Akiyama K
    J Rheumatol; 2012 May; 39(5):1019-25. PubMed ID: 22467925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rituximab as Induction Therapy in Eosinophilic Granulomatosis with Polyangiitis Refractory to Conventional Immunosuppressive Treatment: A 36-Month Follow-Up Analysis.
    Thiel J; Troilo A; Salzer U; Schleyer T; Halmschlag K; Rizzi M; Frede N; Venhoff A; Voll RE; Venhoff N
    J Allergy Clin Immunol Pract; 2017; 5(6):1556-1563. PubMed ID: 28916432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A rare case report of polyangiitis overlap syndrome: granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis.
    Quan MV; Frankel SK; Maleki-Fischbach M; Tan LD
    BMC Pulm Med; 2018 Nov; 18(1):181. PubMed ID: 30497438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased interleukin-27 production by antigen-presenting cells promotes regulatory T cell differentiation and contributes to inducing a remission in patients with eosinophilic granulomatosis with polyangiitis.
    Saito H; Tsurikisawa N; Oshikata C; Tsuburai T; Akiyama K
    Int Arch Allergy Immunol; 2013; 161 Suppl 2():66-74. PubMed ID: 23711856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CTLA-4 blockade following relapse of malignancy after allogeneic stem cell transplantation is associated with T cell activation but not with increased levels of T regulatory cells.
    Zhou J; Bashey A; Zhong R; Corringham S; Messer K; Pu M; Ma W; Chut T; Soiffer R; Mitrovich RC; Lowy I; Ball ED
    Biol Blood Marrow Transplant; 2011 May; 17(5):682-92. PubMed ID: 20713164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Churg-Strauss syndrome.
    Greco A; Rizzo MI; De Virgilio A; Gallo A; Fusconi M; Ruoppolo G; Altissimi G; De Vincentiis M
    Autoimmun Rev; 2015 Apr; 14(4):341-8. PubMed ID: 25500434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose intravenous immunoglobulin therapy for eosinophilic granulomatosis with polyangiitis.
    Tsurikisawa N; Saito H; Oshikata C; Tsuburai T; Akiyama K
    Clin Transl Allergy; 2014; 4():38. PubMed ID: 25937899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revisiting the systemic vasculitis in eosinophilic granulomatosis with polyangiitis (Churg-Strauss): A study of 157 patients by the Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires and the European Respiratory Society Taskforce on eosinophilic granulomatosis with polyangiitis (Churg-Strauss).
    Cottin V; Bel E; Bottero P; Dalhoff K; Humbert M; Lazor R; Sinico RA; Sivasothy P; Wechsler ME; Groh M; Marchand-Adam S; Khouatra C; Wallaert B; Taillé C; Delaval P; Cadranel J; Bonniaud P; Prévot G; Hirschi S; Gondouin A; Dunogué B; Chatté G; Briault C; Pagnoux C; Jayne D; Guillevin L; Cordier JF;
    Autoimmun Rev; 2017 Jan; 16(1):1-9. PubMed ID: 27671089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human CD19(+)CD25(high) B regulatory cells suppress proliferation of CD4(+) T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells.
    Kessel A; Haj T; Peri R; Snir A; Melamed D; Sabo E; Toubi E
    Autoimmun Rev; 2012 Jul; 11(9):670-7. PubMed ID: 22155204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rituximab for the treatment of eosinophilic granulomatosis with polyangiitis (Churg-Strauss).
    Mohammad AJ; Hot A; Arndt F; Moosig F; Guerry MJ; Amudala N; Smith R; Sivasothy P; Guillevin L; Merkel PA; Jayne DR
    Ann Rheum Dis; 2016 Feb; 75(2):396-401. PubMed ID: 25467294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eosinophilic granulomatosis with polyangiitis exhibits T cell activation and IgG4 immune response in the tissue; comparison with IgG4-related disease.
    Kubo S; Kanda R; Nawata A; Miyazaki Y; Kawabe A; Hanami K; Nakatsuka K; Saito K; Nakayamada S; Tanaka Y
    RMD Open; 2022 Mar; 8(1):. PubMed ID: 35260476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-severe eosinophilic granulomatosis with polyangiitis: long-term outcomes after remission-induction trial.
    Puéchal X; Pagnoux C; Baron G; Lifermann F; Geffray L; Quémeneur T; Saraux JL; Wislez M; Cottin V; Ruivard M; Limal N; Aouba A; Bonnotte B; Néel A; Agard C; Cohen P; Terrier B; Le Jeunne C; Mouthon L; Ravaud P; Guillevin L;
    Rheumatology (Oxford); 2019 Dec; 58(12):2107-2116. PubMed ID: 31056661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and classification of eosinophilic granulomatosis with polyangiitis (formerly named Churg-Strauss syndrome).
    Mouthon L; Dunogue B; Guillevin L
    J Autoimmun; 2014; 48-49():99-103. PubMed ID: 24530234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic characterization of ex vivo CD4+CD25highCD127low immune regulatory T cells in allergic asthma: pathogenesis relevance of their FoxP3, GITR, CTLA-4 and FAS expressions.
    Pietruczuk M; Eusebio M; Kraszula L; Kupczyk M; Kuna P
    J Biol Regul Homeost Agents; 2012; 26(4):627-39. PubMed ID: 23241113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of PR3-ANCA positivity in eosinophilic granulomatosis with polyangiitis (Churg-Strauss).
    Papo M; Sinico RA; Teixeira V; Venhoff N; Urban ML; Iudici M; Mahrhold J; Locatelli F; Cassone G; Schiavon F; Seeliger B; Neumann T; Kroegel C; Groh M; Marvisi C; Samson M; Barba T; Jayne D; Troilo A; Thiel J; Hellmich B; Monti S; Montecucco C; Salvarani C; Kahn JE; Bonnotte B; Durel CA; Puéchal X; Mouthon L; Guillevin L; Emmi G; Vaglio A; Terrier B;
    Rheumatology (Oxford); 2021 Sep; 60(9):4355-4360. PubMed ID: 33347592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Focus on the Involvement of the Nose and Paranasal Sinuses in Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss Syndrome): Nasal Cytology Reveals Infiltration of Eosinophils as a Very Common Feature.
    Seccia V; Baldini C; Latorre M; Gelardi M; Dallan I; Cristofani-Mencacci L; Sellari-Franceschini S; Bartoli ML; Bacci E; Paggiaro P
    Int Arch Allergy Immunol; 2018; 175(1-2):61-69. PubMed ID: 29393242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-IgE Monoclonal Antibody (Omalizumab) in Refractory and Relapsing Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss): Data on Seventeen Patients.
    Jachiet M; Samson M; Cottin V; Kahn JE; Le Guenno G; Bonniaud P; Devilliers H; Bouillet L; Gondouin A; Makhlouf F; Meaux-Ruault N; Gil H; Bienvenu B; Coste A; Groh M; Giraud V; Dominique S; Godeau B; Puéchal X; Khouatra C; Ruivard M; Le Jeunne C; Mouthon L; Guillevin L; Terrier B;
    Arthritis Rheumatol; 2016 Sep; 68(9):2274-82. PubMed ID: 26946346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.